Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Optimization of Antitumor Modulators of Pre-mRNA Splicing
Chandraiah Lagisetti, Gustavo Palacios, Tinopiwa Goronga, et al.
Journal of Medicinal Chemistry (2013) Vol. 56, Iss. 24, pp. 10033-10044
Open Access | Times Cited: 59

Showing 1-25 of 59 citing articles:

The use of spirocyclic scaffolds in drug discovery
Ya‐Jun Zheng, Colin M. Tice, Suresh B. Singh
Bioorganic & Medicinal Chemistry Letters (2014) Vol. 24, Iss. 16, pp. 3673-3682
Open Access | Times Cited: 885
Therapeutic targeting of splicing in cancer
Stanley Chun-Wei Lee, Omar Abdel‐Wahab
Nature Medicine (2016) Vol. 22, Iss. 9, pp. 976-986
Open Access | Times Cited: 503
The spliceosome is a therapeutic vulnerability in MYC-driven cancer
Tiffany Hsu, Lukas M. Simon, Nicholas J. Neill, et al.
Nature (2015) Vol. 525, Iss. 7569, pp. 384-388
Open Access | Times Cited: 468
The role of alternative splicing in cancer: From oncogenesis to drug resistance
Rocco Sciarrillo, Anna Wojtuszkiewicz, Yehuda G. Assaraf, et al.
Drug Resistance Updates (2020) Vol. 53, pp. 100728-100728
Open Access | Times Cited: 197
Spliceosome-targeted therapies trigger an antiviral immune response in triple-negative breast cancer
Elizabeth A. Bowling, Jarey H. Wang, Fade Gong, et al.
Cell (2021) Vol. 184, Iss. 2, pp. 384-403.e21
Open Access | Times Cited: 149
Modulating splicing with small molecular inhibitors of the spliceosome
Kerstin A. Effenberger, Veronica K. Urabe, Melissa S. Jurica
Wiley Interdisciplinary Reviews - RNA (2016) Vol. 8, Iss. 2
Open Access | Times Cited: 158
Structural Basis of Splicing Modulation by Antitumor Macrolide Compounds
Constantin Cretu, Anant A. Agrawal, Andrew S. Cook, et al.
Molecular Cell (2018) Vol. 70, Iss. 2, pp. 265-273.e8
Open Access | Times Cited: 151
Small Molecule Modulators of Pre-mRNA Splicing in Cancer Therapy
Maayan Salton, Tom Misteli
Trends in Molecular Medicine (2015) Vol. 22, Iss. 1, pp. 28-37
Open Access | Times Cited: 147
The pathogenicity of splicing defects: mechanistic insights into pre‐ mRNA processing inform novel therapeutic approaches
Élisabeth Daguenet, Gwendal Dujardin, Juan Valcárcel
EMBO Reports (2015) Vol. 16, Iss. 12, pp. 1640-1655
Open Access | Times Cited: 135
Splicing modulators act at the branch point adenosine binding pocket defined by the PHF5A–SF3b complex
Teng Teng, Jennifer Tsai, Xiaoling Puyang, et al.
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 133
Splicing factor gene mutations in hematologic malignancies
Borja Sáez, Matthew J. Walter, Timothy A. Graubert
Blood (2016) Vol. 129, Iss. 10, pp. 1260-1269
Open Access | Times Cited: 120
Mutant U2AF1-expressing cells are sensitive to pharmacological modulation of the spliceosome
Cara Lunn Shirai, Brian S. White, Manorama Tripathi, et al.
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 113
Alternative Splicing as a Target for Cancer Treatment
Nancy Martínez-Montiel, Nora Hilda Rosas-Murrieta, Maricruz Anaya-Ruı́z, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 2, pp. 545-545
Open Access | Times Cited: 104
Interchangeable SF3B1 inhibitors interfere with pre-mRNA splicing at multiple stages
Kerstin A. Effenberger, Veronica K. Urabe, Beth E. Prichard, et al.
RNA (2016) Vol. 22, Iss. 3, pp. 350-359
Open Access | Times Cited: 79
The splicing modulator sudemycin induces a specific antitumor response and cooperates with ibrutinib in chronic lymphocytic leukemia
Sílvia Xargay‐Torrent, Mònica López‐Guerra, Laia Rosich, et al.
Oncotarget (2015) Vol. 6, Iss. 26, pp. 22734-22749
Open Access | Times Cited: 66
Splicing modulators: on the way from nature to clinic
Tilman Schneider‐Poetsch, Jagat K Chhipi-Shrestha, Minoru Yoshida
The Journal of Antibiotics (2021) Vol. 74, Iss. 10, pp. 603-616
Open Access | Times Cited: 43
Inhibition of SF3B1 by molecules targeting the spliceosome results in massive aberrant exon skipping
Gang Wu, Liying Fan, Michael N. Edmonson, et al.
RNA (2018) Vol. 24, Iss. 8, pp. 1056-1066
Open Access | Times Cited: 55
Total Syntheses of Thailanstatins A–C, Spliceostatin D, and Analogues Thereof. Stereodivergent Synthesis of Tetrasubstituted Dihydro- and Tetrahydropyrans and Design, Synthesis, Biological Evaluation, and Discovery of Potent Antitumor Agents
K. C. Nicolaou, Derek Rhoades, Sanjay Kumar
Journal of the American Chemical Society (2018) Vol. 140, Iss. 26, pp. 8303-8320
Closed Access | Times Cited: 52
Hereditary retinoblastoma iPSC model reveals aberrant spliceosome function driving bone malignancies
Jian Tu, Zijun Huo, Yao Yu, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 16
Open Access | Times Cited: 25
Investigating the Potential Roles of SINEs in the Human Genome
Xiao‐Ou Zhang, Henry Pratt, Zhiping Weng
Annual Review of Genomics and Human Genetics (2021) Vol. 22, Iss. 1, pp. 199-218
Open Access | Times Cited: 32
A synthetic small molecule stalls pre-mRNA splicing by promoting an early-stage U2AF2-RNA complex
Rakesh Chatrikhi, Callen F. Feeney, Mary J. Pulvino, et al.
Cell chemical biology (2021) Vol. 28, Iss. 8, pp. 1145-1157.e6
Open Access | Times Cited: 31
Omics wise analysis of RNA splicing
Alexander Modestov, Anton Buzdin, Vladimir Prassolov
Elsevier eBooks (2025), pp. 213-229
Closed Access
Epigenetically silenced long noncoding-SRHC promotes proliferation of hepatocellular carcinoma
Hao Zheng, Sen Yang, Yuan Yang, et al.
Journal of Cancer Research and Clinical Oncology (2014) Vol. 141, Iss. 7, pp. 1195-1203
Closed Access | Times Cited: 36
A Challenging Pie to Splice: Drugging the Spliceosome
Brian León, Manoj Kumar Kashyap, Warren C. W. Chan, et al.
Angewandte Chemie International Edition (2017) Vol. 56, Iss. 40, pp. 12052-12063
Open Access | Times Cited: 34
Sudemycin K: A Synthetic Antitumor Splicing Inhibitor Variant with Improved Activity and Versatile Chemistry
Kamil Makowski, Luisa Vigevani, Fernando Alberício, et al.
ACS Chemical Biology (2016) Vol. 12, Iss. 1, pp. 163-173
Open Access | Times Cited: 25
Page 1 - Next Page

Scroll to top